Regions Financial Corp’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Regions Financial Corp’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,021	Closed	-$17K	–	1791
2019 Q1	$17K	Hold	1,021	–	–	﹤0.01%	1412
2018 Q4	$12K	Hold	1,021	–	–	﹤0.01%	1480
2018 Q3	$41K	Hold	1,021	–	–	﹤0.01%	1268
2018 Q2	$29K	Buy	+1,021	New	+$22.6K	﹤0.01%	1355

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Regions Financial Corp's MRNS Position: Q2 2019 in Review

Regions Financial Corp sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2019, closing a stake of 1,021 shares — an estimated $17K sold.

Regions Financial Corp first reported a position in MRNS in Q2 2018 and held it in 4 quarters. The position peaked at $41K in Q3 2018. 77 funds tracked by Wall St. Rank hold MRNS as of Q2 2019.

Regions Financial Corp reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 1,021 Marinus Pharmaceuticals, Inc shares in Q2 2019, an estimated $17K.
Regions Financial Corp first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 4 quarters.
Regions Financial Corp's Marinus Pharmaceuticals, Inc position peaked at $41K in Q3 2018.
77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.